Amgen Inc (AMG.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
At close: 07:40PM CEST
| Previous close | 287.30 |
| Open | 290.85 |
| Bid | 289.05 x 200000 |
| Ask | 289.80 x 300000 |
| Day's range | 289.95 - 290.85 |
| 52-week range | 197.70 - 303.00 |
| Volume | |
| Avg. volume | 197 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Zacks5 Stocks Driving Dow's Market-Beating Performance
Dow Jones outperforms at the start of May as the market rally broadens and reconstruction of the index finally pays off.
PR NewswireAMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE
Amgen (NASDAQ:AMGN) will present at the Bank of America Merrill Lynch Global Healthcare Conference at 9:20 a.m. PT on Tuesday, May 14, 2024. Peter Griffith, executive vice president and chief financial officer at Amgen, and Jay Bradner, executive vice president of Research and Development and chief scientific officer at Amgen, will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the genera
- Thomson Reuters StreetEvents
Q1 2024 CytomX Therapeutics Inc Earnings Call
Q1 2024 CytomX Therapeutics Inc Earnings Call
© 2024 Yahoo. All rights reserved.